Version 1 of 1 (2005-02-17 to 2005-06-10) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
Corporation: |
CANADIAN COMMITTEE ON ANTIBIOTIC RESISTANCE
3806 W 33 AVE VANCOUVER, BC V6N 2H6 Canada |
||||
Telephone number: | 604-263-4520 | ||||
Fax number: | 604-263-7074 | ||||
Responsible officer name and position during the period of this registration: | RICK WALTER, EXECUTIVE DIRECTOR | ||||
Description of activities: | CCAR ADVOCATES FOR AND FACILIATES PROGRAMS RELATED TO SURVEIULLANCE, INFECTINO PREVENTINO AND CONTROL AND OPRIMAL ANTIBIOTIC USE TO LIMIT THE DEVELOPMENT AND TRANSMISSION OF ANTIBIOTIC RESISTANCE IN CANADA. | ||||
Parent: | The corporation is not a subsidiary of any other parent corporations. | ||||
Coalition | The corporation is not a member of a coalition. | ||||
Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. | ||||
Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. | ||||
Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | Yes | ||||
End date of the corporation's last completed financial year: | 2006-03-31 | ||||
|
Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | PUBLIC HEALTH AGENCY |
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format |
Subject Matter: Areas of Concern: | Agriculture, Consumer Issues, Education, Health, Science and Technology |
Subject Matter: Particulars: | INTERESTED IN ALL POLICIES, PROCEDURES AND PROGRAMS WHICH HAVE AN IMPACT ON ANTIBIOTIC RESISTANCE AND THE USE OF ANTIBIOTICS. |